Syndax Pharmaceuticals
Top stories
Latest
- Analyzing Fate Therapeutics (NASDAQ:FATE) and Syndax Pharmaceuticals (NASDAQ:SNDX)themarketsdaily.com · 2026-10-03 13:06 UTC · story
- Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire — public companies · 2026-10-02 20:01 UTC · story